Tsui K, Wu M, Lin L, Wen Z, Li Y, Chu P
Theranostics. 2019; 9(22):6631-6645.
PMID: 31588240
PMC: 6771251.
DOI: 10.7150/thno.33353.
Sibley C, Price R
Int J Parasitol Drugs Drug Resist. 2014; 2:126-33.
PMID: 24533274
PMC: 3862427.
DOI: 10.1016/j.ijpddr.2012.03.004.
Mugoyela V, Minzi O
Risk Manag Healthc Policy. 2012; 4:89-95.
PMID: 22312231
PMC: 3270926.
DOI: 10.2147/RMHP.S23054.
Agarwal J, Singh S, Chanda D, Bawankule D, Bhakuni R, Pal A
Parasitol Res. 2011; 109(4):1003-8.
PMID: 21541755
DOI: 10.1007/s00436-011-2344-1.
Innocent E, Moshi M, Masimba P, Mbwambo Z, Kapingu M, Kamuhabwa A
Afr J Tradit Complement Altern Med. 2010; 6(2):163-7.
PMID: 20209008
PMC: 2816569.
DOI: 10.4314/ajtcam.v6i2.57088.
Effect of artemisinin derivatives on apoptosis and cell cycle in prostate cancer cells.
Morrissey C, Gallis B, Solazzi J, Kim B, Gulati R, Vakar-Lopez F
Anticancer Drugs. 2010; 21(4):423-32.
PMID: 20130467
PMC: 2953769.
DOI: 10.1097/CAD.0b013e328336f57b.
Artemisinin blocks prostate cancer growth and cell cycle progression by disrupting Sp1 interactions with the cyclin-dependent kinase-4 (CDK4) promoter and inhibiting CDK4 gene expression.
Willoughby Sr J, Sundar S, Cheung M, Tin A, Modiano J, Firestone G
J Biol Chem. 2008; 284(4):2203-13.
PMID: 19017637
PMC: 2629082.
DOI: 10.1074/jbc.M804491200.
Prospects for the treatment of drug-resistant malaria parasites.
Tilley L, Davis T, Bray P
Future Microbiol. 2007; 1(1):127-41.
PMID: 17661691
PMC: 7117597.
DOI: 10.2217/17460913.1.1.127.
Putting the genie back in the bottle? Availability and presentation of oral artemisinin compounds at retail pharmacies in urban Dar-es-Salaam.
Kachur S, Black C, Abdulla S, Goodman C
Malar J. 2006; 5:25.
PMID: 16569252
PMC: 1444918.
DOI: 10.1186/1475-2875-5-25.
Effect of artemether-lumefantrine policy and improved vector control on malaria burden in KwaZulu-Natal, South Africa.
Barnes K, Durrheim D, Little F, Jackson A, Mehta U, Allen E
PLoS Med. 2005; 2(11):e330.
PMID: 16187798
PMC: 1240068.
DOI: 10.1371/journal.pmed.0020330.
The benefits of artemisinin combination therapy for malaria extend beyond the individual patient.
Garner P, Graves P
PLoS Med. 2005; 2(4):e105.
PMID: 15839750
PMC: 1087214.
DOI: 10.1371/journal.pmed.0020105.
Piperaquine: a resurgent antimalarial drug.
Davis T, Hung T, Sim I, Karunajeewa H, Ilett K
Drugs. 2004; 65(1):75-87.
PMID: 15610051
DOI: 10.2165/00003495-200565010-00004.
